Mexico has inaugurated a $140 million lab to manufacture influenza vaccines, a year-and-a-half after it attracted worldwide attention as ground zero of the H1N1 swine flu. President Felipe Calderon says the facility built and operated by French company Sanofi-Pasteur will help Mexico be better prepared to deal with a flu pandemic.

Sanofi-Pasteur says in a statement that the plant will produce 30 million doses of antigen, the key vaccine ingredient, annually and that a government-run manufacturer will finish the production and distribute the vaccine. The plant was built outside Mexico City and inaugurated Friday.


•  Fifth confirmed case of influenza A H1N1 in Bolivia (translated) (Link)

•  Ontario: Spike in flu cases expected (Link)

•  Province of Alberta: Thousands seek flu shots in Calgary (Link)

•  Indonesia announces two bird flu cases (Link and translation)

•  Swine flu cases drop in India (Link)
•  Hyderabad research firm announces India’s first cell-cultured H1N1 swine flu vaccine news (Link)

South Korea
•  Low-path H7N7 in birds (Link)

United Kingdom
•  Workers offered free flu jabs (Link)

•  Wales: Health chief warns of a rise in deaths from low take-up of flu jab (Link)

United States
•  Nebraska: Flu Tracking Begins (Link)

•  Outbreak of swine flu in Matabeleland (Link)
•  Mysterious flu bug affects thousands in Zimbabwe (Link)

•  Swine/H1N1 Flu resurfaces in Southern Africa (Link)
•  ProMED article on the outbreak of influenza in Zimbabwe (Link)

•  Touchscreen Cell Phones Are Really, Really Dirty (Link)

•  Recombinomics: Worldwide Spread of H1N1 S188T Via Clonal Expansion (Link)

•  The fear of the researchers has been confirmed: Variants of the H1N1 virus are resistant to current drugs (Link)